Canadian Cancer Society logo

Multiple myeloma

You are here: 

Consolidation therapy for multiple myeloma

Consolidation therapy for multiple myeloma is given after a stem cell transplant. It’s a short course of chemotherapy that helps make the previous chemotherapy treatment and stem cell transplant work better. Consolidation therapy also helps to keep the multiple myeloma in remission for longer.

Consolidation therapy for people with multiple myeloma who have had a stem cell transplant is most often the VRD regimen. The VRD regimen uses bortezomib (Velcade), lenalidomide (Revlimid) and dexamethasone (Decadron, Dexasone).

Stories

Researcher Dr Raymond Andersen Dr Raymond Andersen’s research could lead to a promising new drug for prostate cancer.

Learn more

Celebrating cancer survivors at Relay For Life

Relay For Life illustration

For cancer survivors, the Canadian Cancer Society provides a unique opportunity to celebrate their courage in the fight against cancer. During hundreds of Relay For Life events across the country, thousands of survivors join together for the Survivors’ Victory Lap.

Learn more